nodes	percent_of_prediction	percent_of_DWPC	metapath
Clenbuterol—CYP1A1—lung cancer	0.553	1	CbGaD
Clenbuterol—CYP1A1—Gefitinib—lung cancer	0.102	0.489	CbGbCtD
Clenbuterol—CYP1A1—Erlotinib—lung cancer	0.0602	0.289	CbGbCtD
Clenbuterol—CYP1A2—Erlotinib—lung cancer	0.0269	0.129	CbGbCtD
Clenbuterol—CYP1A2—Etoposide—lung cancer	0.0194	0.0934	CbGbCtD
Clenbuterol—ADRB2—Signaling Pathways—FOXO3—lung cancer	1.54e-05	6.48e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MAP2K1—lung cancer	1.54e-05	6.46e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—PIK3CD—lung cancer	1.54e-05	6.44e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PIK3CD—lung cancer	1.53e-05	6.41e-05	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—IL6—lung cancer	1.52e-05	6.39e-05	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TP53—lung cancer	1.52e-05	6.37e-05	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—PIK3CA—lung cancer	1.52e-05	6.35e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—MAP2K1—lung cancer	1.51e-05	6.35e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—PIK3CD—lung cancer	1.5e-05	6.3e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GSTA4—lung cancer	1.5e-05	6.3e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—KRAS—lung cancer	1.5e-05	6.28e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—AVP—lung cancer	1.48e-05	6.2e-05	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—PIK3CB—lung cancer	1.48e-05	6.19e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.47e-05	6.16e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GSTA2—lung cancer	1.47e-05	6.14e-05	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—HRAS—lung cancer	1.45e-05	6.09e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—AVP—lung cancer	1.45e-05	6.07e-05	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—PIK3CB—lung cancer	1.44e-05	6.05e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CYP2E1—lung cancer	1.43e-05	5.99e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IGF1R—lung cancer	1.42e-05	5.97e-05	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CXCL8—lung cancer	1.42e-05	5.94e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GSTA1—lung cancer	1.41e-05	5.93e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—NQO1—lung cancer	1.41e-05	5.92e-05	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—AKT1—lung cancer	1.41e-05	5.89e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HES1—lung cancer	1.4e-05	5.87e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ABCC3—lung cancer	1.4e-05	5.86e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IGF1R—lung cancer	1.39e-05	5.84e-05	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—IL6—lung cancer	1.39e-05	5.83e-05	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CXCL8—lung cancer	1.39e-05	5.81e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.38e-05	5.8e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—PIK3CA—lung cancer	1.38e-05	5.77e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—RAF1—lung cancer	1.37e-05	5.75e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.37e-05	5.75e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MDM2—lung cancer	1.37e-05	5.75e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HES1—lung cancer	1.37e-05	5.74e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—RAF1—lung cancer	1.37e-05	5.73e-05	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—IL2—lung cancer	1.36e-05	5.68e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—AKR1C1—lung cancer	1.35e-05	5.68e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—ERBB2—lung cancer	1.35e-05	5.67e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—RAF1—lung cancer	1.34e-05	5.63e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—PIK3CB—lung cancer	1.34e-05	5.62e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PIK3CB—lung cancer	1.33e-05	5.59e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MTOR—lung cancer	1.33e-05	5.59e-05	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—IL2—lung cancer	1.33e-05	5.56e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—UGT1A1—lung cancer	1.31e-05	5.51e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—PIK3CB—lung cancer	1.31e-05	5.49e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CXCL8—lung cancer	1.29e-05	5.4e-05	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—AKT1—lung cancer	1.28e-05	5.38e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CXCL8—lung cancer	1.28e-05	5.37e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—ERBB3—lung cancer	1.28e-05	5.36e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—STK11—lung cancer	1.27e-05	5.34e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—HRAS—lung cancer	1.27e-05	5.34e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GNG11—lung cancer	1.27e-05	5.31e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.26e-05	5.29e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CXCL8—lung cancer	1.26e-05	5.28e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—ERBB3—lung cancer	1.25e-05	5.25e-05	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—AKT1—lung cancer	1.24e-05	5.19e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—IL2—lung cancer	1.23e-05	5.16e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CASP3—lung cancer	1.23e-05	5.14e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TERT—lung cancer	1.23e-05	5.14e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IL2—lung cancer	1.22e-05	5.13e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—IL6—lung cancer	1.22e-05	5.11e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ALDOA—lung cancer	1.21e-05	5.06e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—IL2—lung cancer	1.2e-05	5.05e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TERT—lung cancer	1.2e-05	5.03e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.2e-05	5.01e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CCND1—lung cancer	1.19e-05	5.01e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—JUN—lung cancer	1.19e-05	4.99e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—FGFR1—lung cancer	1.19e-05	4.99e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GSTP1—lung cancer	1.18e-05	4.94e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HIF1A—lung cancer	1.17e-05	4.92e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—NCOA3—lung cancer	1.17e-05	4.91e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—FGFR1—lung cancer	1.16e-05	4.88e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MMP9—lung cancer	1.16e-05	4.86e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CDKN1A—lung cancer	1.16e-05	4.84e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PTEN—lung cancer	1.15e-05	4.83e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.15e-05	4.83e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HIF1A—lung cancer	1.15e-05	4.81e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CAT—lung cancer	1.15e-05	4.81e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.14e-05	4.78e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ABCG2—lung cancer	1.14e-05	4.78e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ADCY1—lung cancer	1.14e-05	4.78e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—APOA1—lung cancer	1.13e-05	4.74e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—AKT1—lung cancer	1.12e-05	4.71e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—KDR—lung cancer	1.12e-05	4.7e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—HPGDS—lung cancer	1.12e-05	4.69e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ENO2—lung cancer	1.12e-05	4.69e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ABCB1—lung cancer	1.12e-05	4.68e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PPP2R1B—lung cancer	1.11e-05	4.66e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—APOA1—lung cancer	1.11e-05	4.64e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—EP300—lung cancer	1.1e-05	4.61e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—KDR—lung cancer	1.1e-05	4.6e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.1e-05	4.59e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—TYMS—lung cancer	1.1e-05	4.59e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GSTT1—lung cancer	1.08e-05	4.54e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GSTM1—lung cancer	1.08e-05	4.54e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GCLC—lung cancer	1.07e-05	4.49e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CYP2A6—lung cancer	1.07e-05	4.49e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—SRC—lung cancer	1.07e-05	4.48e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.07e-05	4.47e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—VEGFA—lung cancer	1.04e-05	4.36e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—KIT—lung cancer	1.03e-05	4.33e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—APC—lung cancer	1.03e-05	4.33e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PIK3CG—lung cancer	1.03e-05	4.33e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—NRAS—lung cancer	1.03e-05	4.33e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—STAT3—lung cancer	1.03e-05	4.32e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—NRAS—lung cancer	1.03e-05	4.31e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—EGF—lung cancer	1.02e-05	4.28e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ERCC2—lung cancer	1.02e-05	4.27e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ENO1—lung cancer	1.02e-05	4.26e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.01e-05	4.24e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—APC—lung cancer	1.01e-05	4.24e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PIK3CG—lung cancer	1.01e-05	4.24e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—KIT—lung cancer	1.01e-05	4.24e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—NRAS—lung cancer	1.01e-05	4.24e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	9.99e-06	4.19e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—EGF—lung cancer	9.99e-06	4.19e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—MAPK3—lung cancer	9.89e-06	4.15e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MAPK3—lung cancer	9.85e-06	4.13e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—POMC—lung cancer	9.83e-06	4.12e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—BRAF—lung cancer	9.71e-06	4.07e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—MAPK3—lung cancer	9.68e-06	4.06e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—POMC—lung cancer	9.62e-06	4.03e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IL6R—lung cancer	9.59e-06	4.02e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CREBBP—lung cancer	9.58e-06	4.02e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MYC—lung cancer	9.58e-06	4.01e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—BRAF—lung cancer	9.5e-06	3.98e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—EGFR—lung cancer	9.41e-06	3.95e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IL6R—lung cancer	9.38e-06	3.93e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CREBBP—lung cancer	9.37e-06	3.93e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—EGFR—lung cancer	9.37e-06	3.93e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—EGFR—lung cancer	9.21e-06	3.86e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MAP2K1—lung cancer	9.14e-06	3.83e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CYP2E1—lung cancer	9.11e-06	3.82e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PIK3CD—lung cancer	9.08e-06	3.81e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—NQO1—lung cancer	9.01e-06	3.78e-05	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—PIK3CA—lung cancer	9e-06	3.77e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MAP2K1—lung cancer	8.94e-06	3.75e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—KRAS—lung cancer	8.89e-06	3.73e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PIK3CD—lung cancer	8.88e-06	3.72e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—KRAS—lung cancer	8.85e-06	3.71e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	8.82e-06	3.7e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—APOA1—lung cancer	8.81e-06	3.69e-05	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—PIK3CA—lung cancer	8.8e-06	3.69e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	8.74e-06	3.66e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—KRAS—lung cancer	8.7e-06	3.65e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	8.43e-06	3.54e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—PIK3CA—lung cancer	8.17e-06	3.42e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MDM2—lung cancer	8.14e-06	3.41e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PIK3CA—lung cancer	8.13e-06	3.41e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—STK11—lung cancer	8.12e-06	3.4e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—RAF1—lung cancer	8.11e-06	3.4e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PIK3CG—lung cancer	8.04e-06	3.37e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—ERBB2—lung cancer	8.02e-06	3.36e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—PIK3CA—lung cancer	7.99e-06	3.35e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MDM2—lung cancer	7.96e-06	3.34e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—RAF1—lung cancer	7.93e-06	3.32e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MTOR—lung cancer	7.92e-06	3.32e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PIK3CB—lung cancer	7.92e-06	3.32e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TP53—lung cancer	7.87e-06	3.3e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—ERBB2—lung cancer	7.85e-06	3.29e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MTOR—lung cancer	7.74e-06	3.25e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PIK3CB—lung cancer	7.74e-06	3.25e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—POMC—lung cancer	7.65e-06	3.21e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	7.62e-06	3.2e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CXCL8—lung cancer	7.61e-06	3.19e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—HRAS—lung cancer	7.56e-06	3.17e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—HRAS—lung cancer	7.52e-06	3.15e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GSTP1—lung cancer	7.51e-06	3.15e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CREBBP—lung cancer	7.46e-06	3.13e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CXCL8—lung cancer	7.44e-06	3.12e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—HRAS—lung cancer	7.39e-06	3.1e-05	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—AKT1—lung cancer	7.35e-06	3.08e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CAT—lung cancer	7.31e-06	3.07e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CASP3—lung cancer	7.28e-06	3.05e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	7.27e-06	3.05e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IL2—lung cancer	7.27e-06	3.05e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—IL6—lung cancer	7.23e-06	3.03e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IL6—lung cancer	7.2e-06	3.02e-05	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—AKT1—lung cancer	7.19e-06	3.01e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CASP3—lung cancer	7.12e-06	2.99e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ABCB1—lung cancer	7.11e-06	2.98e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IL2—lung cancer	7.11e-06	2.98e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCND1—lung cancer	7.09e-06	2.97e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—IL6—lung cancer	7.08e-06	2.97e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—JUN—lung cancer	7.07e-06	2.96e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PIK3CD—lung cancer	7.07e-06	2.96e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—TYMS—lung cancer	6.99e-06	2.93e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ALB—lung cancer	6.98e-06	2.93e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCND1—lung cancer	6.93e-06	2.91e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—JUN—lung cancer	6.92e-06	2.9e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GSTM1—lung cancer	6.91e-06	2.89e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MMP9—lung cancer	6.88e-06	2.88e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CDKN1A—lung cancer	6.86e-06	2.87e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PTEN—lung cancer	6.84e-06	2.87e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MMP9—lung cancer	6.73e-06	2.82e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CDKN1A—lung cancer	6.71e-06	2.81e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PTEN—lung cancer	6.69e-06	2.8e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—AKT1—lung cancer	6.67e-06	2.8e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—AKT1—lung cancer	6.64e-06	2.78e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CYP1A1—lung cancer	6.55e-06	2.74e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—AKT1—lung cancer	6.53e-06	2.74e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—EP300—lung cancer	6.52e-06	2.73e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ERCC2—lung cancer	6.49e-06	2.72e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—EP300—lung cancer	6.38e-06	2.68e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—SRC—lung cancer	6.34e-06	2.66e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—SRC—lung cancer	6.21e-06	2.6e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—VEGFA—lung cancer	6.18e-06	2.59e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PIK3CB—lung cancer	6.16e-06	2.58e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—STAT3—lung cancer	6.12e-06	2.56e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PTGS2—lung cancer	6.11e-06	2.56e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NRAS—lung cancer	6.1e-06	2.56e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—VEGFA—lung cancer	6.04e-06	2.53e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—STAT3—lung cancer	5.98e-06	2.51e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NRAS—lung cancer	5.97e-06	2.5e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MAPK3—lung cancer	5.84e-06	2.45e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MAPK3—lung cancer	5.72e-06	2.4e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MYC—lung cancer	5.68e-06	2.38e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—APOA1—lung cancer	5.62e-06	2.35e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MYC—lung cancer	5.56e-06	2.33e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—EGFR—lung cancer	5.56e-06	2.33e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—EGFR—lung cancer	5.44e-06	2.28e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.38e-06	2.25e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PTEN—lung cancer	5.32e-06	2.23e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—KRAS—lung cancer	5.25e-06	2.2e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—KRAS—lung cancer	5.14e-06	2.15e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PIK3CG—lung cancer	5.13e-06	2.15e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—EP300—lung cancer	5.08e-06	2.13e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—POMC—lung cancer	4.88e-06	2.05e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PIK3CA—lung cancer	4.83e-06	2.02e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CREBBP—lung cancer	4.75e-06	1.99e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PIK3CA—lung cancer	4.72e-06	1.98e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TP53—lung cancer	4.67e-06	1.96e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TP53—lung cancer	4.57e-06	1.91e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PIK3CD—lung cancer	4.51e-06	1.89e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HRAS—lung cancer	4.46e-06	1.87e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ALB—lung cancer	4.45e-06	1.87e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HRAS—lung cancer	4.37e-06	1.83e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IL6—lung cancer	4.27e-06	1.79e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IL6—lung cancer	4.18e-06	1.75e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—AKT1—lung cancer	3.94e-06	1.65e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PIK3CB—lung cancer	3.93e-06	1.65e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PTGS2—lung cancer	3.89e-06	1.63e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—AKT1—lung cancer	3.86e-06	1.62e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PIK3CA—lung cancer	3.76e-06	1.57e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PTEN—lung cancer	3.4e-06	1.42e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—EP300—lung cancer	3.24e-06	1.36e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—AKT1—lung cancer	3.07e-06	1.29e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PIK3CA—lung cancer	2.4e-06	1e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—AKT1—lung cancer	1.96e-06	8.2e-06	CbGpPWpGaD
